Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma

Ajou University School of Medicine

Status: Unknown

Conditions: Neutropenia, Febrile; Diffuse Large B Cell Lymphoma

Study type: Observational

Funder types: Other

Identifiers

NCT02474550

AJIRB-MED-OBS-14-254

Details and patient eligibility

About

This study was designed to review clincal outcomes of Diffuse Large B Cell Lymphoma (DLBCL) treated with R-CHOP chemotherapy in the era of pegylated-filgrastim. The investigators will prospectively collect clinical data and treatment outcome of patients with DLBCL who use prophylactic pegylated-filgrastim.

Full description

• Newly diagnosed DLBCL patients treated with R-CHOP chemotherapy
• Prphylactic peg-filgrastim on the day after chemotherapy

Enrollment: 1,000 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 19 or older
• newly diagnosed with DLBCL
• R-CHOP chemotherapy
• offer informed consent

Exclusion criteria

• other subtype of NHL
• concomitant other cancer
• previous chemotherapy or radiotherapy

Trial design

1,000 participants in 1 patient group

CISL 14-03

Description:

* Patients who were newly diagnosed with Diffuse Large B cell Lymphoma (DLBCL). * Aged 19 or more * Treated with R-CHOP therapy